Celldex Therapeutics reported a wider quarterly and year to date loss but slightly lower loss per share, alongside very limited revenue, while also putting a universal shelf registration in place that...
Source LinkCelldex Therapeutics reported a wider quarterly and year to date loss but slightly lower loss per share, alongside very limited revenue, while also putting a universal shelf registration in place that...
Source Link
Comments